Incorporation and release behavior of hydrophobic drug in functionalized poly(D,L-lactide)-block-poly(ethylene oxide) micelles

被引:190
作者
Lee, JY [1 ]
Cho, EC [1 ]
Cho, K [1 ]
机构
[1] Pohang Univ Sci & Technol, Sch Environm Engn, Dept Chem Engn, Pohang 790784, South Korea
关键词
block copolymer; micelle; nanoparticle; drug delivery; careboxylic acid;
D O I
10.1016/j.jconrel.2003.10.012
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The poly(ethylene oxide)-poly(lactide) (PEO-PLA) block copolymers containing a small quantity of carboxylic acid in the PLA block were synthesized. The microscopic characteristics of nanoparticles with carboxylic acid content in the copolymer were analyzed, and the effect of specific interactions between the copolymer and the model drug on the drug loading capacity and the release behavior were investigated systematically. The sizes of nanoparticles prepared by a dialysis method are within the range of 30-40 nm. The nanoparticles prepared from functionalized block copolymers have a very low critical micelle concentration (CMC) value as low as similar to10(-3) mg/ml, which indicates a good stability of the nanoparticles in spite of the presence of carboxylic acid. The drug loading efficiency of nanoparticles dramatically increased when carboxylic acid content was increased in the block copolymer. This result may be attributed to the increase of interactions between the copolymer and the drug. The release rate of the drug was much slower from nanoparticles containing higher amounts of carboxylic acid in the copolymer, which might be associated with the enhanced interaction between the carboxylic group of copolymers and the drug. These experimental results suggest that the nanoparticles prepared from functionalized PEO-PLA block copolymers could be a good candidate for an injectable drug delivery carrier. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 25 条
[1]   Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818 [J].
Allen, C ;
Yu, YS ;
Maysinger, D ;
Eisenberg, A .
BIOCONJUGATE CHEMISTRY, 1998, 9 (05) :564-572
[2]   Nano-engineering block copolymer aggregates for drug delivery [J].
Allen, C ;
Maysinger, D ;
Eisenberg, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :3-27
[3]   Poly(ethylene oxide-co-beta-benzyl L-aspartate) block copolymers: Influence of the poly(ethylene oxide) block on the conformation of the poly(beta-benzyl L-aspartate) segment in organic solvents [J].
Cammas, S ;
Harada, A ;
Nagasaki, Y ;
Kataoka, K .
MACROMOLECULES, 1996, 29 (09) :3227-3231
[4]   Conformational transition of nanoparticles composed of poly(γ-benzyl L-glutamate) as the core and poly(ethylene oxide) as the shell [J].
Cho, CS ;
Nah, JW ;
Jeong, YI ;
Cheon, JB ;
Asayama, S ;
Ise, H ;
Akaike, T .
POLYMER, 1999, 40 (24) :6769-6775
[5]   Enzymatic degradation of blends of poly (ε-caprolactone) and poly(styrene-co-acrylonitrile) by Pseudomonas lipase [J].
Cho, K ;
Lee, J ;
Xing, PX .
JOURNAL OF APPLIED POLYMER SCIENCE, 2002, 83 (04) :868-879
[6]   Enzymatic biodegradation of poly(ethylene oxide-b-ε-caprolactone) diblock copolymer and its potential biomedical applications [J].
Gan, ZH ;
Jim, TF ;
Li, M ;
Yuer, Z ;
Wang, SG ;
Wu, C .
MACROMOLECULES, 1999, 32 (03) :590-594
[7]   A MODEL OF MICELLIZATION FOR BLOCK-COPOLYMERS IN SOLUTIONS [J].
GAO, ZS ;
EISENBERG, A .
MACROMOLECULES, 1993, 26 (26) :7353-7360
[8]   Polylactide-poly(ethylene glycol) copolymers as drug delivery systems .1. Characterization of water dispersible micelle-forming systems [J].
Hagan, SA ;
Coombes, AGA ;
Garnett, MC ;
Dunn, SE ;
Davis, MC ;
Illum, L ;
Davis, SS ;
Harding, SE ;
Purkiss, S ;
Gellert, PR .
LANGMUIR, 1996, 12 (09) :2153-2161
[9]   BIODEGRADABLE POLY(LACTIC ACID) AND POLY(LACTIDE-CO-GLYCOLIDE) MICROCAPSULES - PROBLEMS ASSOCIATED WITH PREPARATIVE TECHNIQUES AND RELEASE PROPERTIES [J].
JALIL, R ;
NIXON, JR .
JOURNAL OF MICROENCAPSULATION, 1990, 7 (03) :297-325
[10]   Polymeric micelles - a new generation of colloidal drug carriers [J].
Jones, MC ;
Leroux, JC .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 48 (02) :101-111